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Background: The Angiotensin-Converting Enzyme-2 (ACE2) gene, located on chromosome X, is believed to be
implicated in blood pressure regulation. However the few studies that have examined this association have yielded
mixed results. The objective of this study was to assess the association between tag single nucleotide polymorphisms
(SNPs) in the angiotensin-converting enzyme-2 gene with blood pressure and blood pressure change in
adolescents.
Methods: Participants in the Nicotine Dependence in Teens (NDIT) cohort study with blood or saliva samples
and at least 3 blood pressure measurements over 5 years were included in the analytic sample (n = 555).
Linear growth curve models stratified on sex and ethnicity were used to assess the association between four
tag SNPs in the ACE2 gene and systolic (SBP) and diastolic blood pressure (DBP), and blood pressure change.
Results: In males of European descent, rs2074192 and rs233575 were significantly associated with SBP and
DBP, and rs2158083 was associated with SBP. In French Canadian males, rs233575 and rs2158083 were
significantly associated with DBP. Among females of European descent, rs2074192, rs233575, and rs2158083
were significantly associated with change in SBP over 5 years.
Conclusions: This is the first study to assess the association between the ACE2 gene with blood pressure
and blood pressure change in a cohort of adolescents. Results indicate that several ACE2 gene SNPs are
associated with blood pressure or blood pressure change in persons of European descent. However the
therapeutic potential of these SNPs should be explored.
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Hypertension (HTN) is a major risk factor for cardiovascu-
lar disease. Half of all strokes and ischemic heart disease,
and 25% of other cardiovascular diseases are due to ele-
vated blood pressure [1]. In 2000, the prevalence of HTN
as defined by systolic blood pressure (SBP) ≥ 140 mmHg or
diastolic blood pressure (DBP) ≥ 90 mmHg was 26% world-
wide [2]. It is estimated that the prevalence will reach 29%
by 2025 [2]. Genetic influences on blood pressure have
been clearly established, with heritability estimates between* Correspondence: gilles.paradis@mcgill.ca
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reproduction in any medium, provided the or0.20 and 0.60 [3-6]. It is thus important to better under-
stand which genes are implicated in the regulation of blood
pressure and how these genes influence blood pressure
levels. Increased understanding of genetic risk could help
identify new therapeutic targets for HTN, as well as distin-
guish population subgroups that may benefit from closer
monitoring and more intensive prevention efforts.
The Angiotensin-Converting Enzyme-2 (ACE2) is a nega-
tive regulator of the renin-angiotensin aldosterone system
[7-9] and plays an important role in blood pressure homeo-
stasis [9]. ACE2, a homolog to the Angiotensin-Converting
Enzyme (ACE), contains a single catalytic site that is 42%
similar to the ACE catalytic sites, and ACE2 and ACE are
believed to have antagonistic effects on blood pressureLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in Ang II peptide levels (a vasoconstrictor substance) with
ACE2 inhibition [9,12], studies of the association between
blood pressure and ACE2 single nucleotide polymorphisms
(SNPs) have yielded mixed results in humans. Studies in
Australian, German, and Han Chinese populations did not
find any association between ACE2 SNPs and blood pres-
sure [11,13,14], while studies in Chinese populations that
were not Han Chinese found statistically significant associa-
tions between two ACE2 SNPs and blood pressure [15,16].
Past studies on ACE2 SNPs were conducted in adults
and were primarily case–control or cross-sectional. The re-
sults are subject to confounding by preexisting chronic dis-
eases or treatments for high blood pressure. Because young
people generally do not have chronic disease or take blood
pressure medications, assessing the association between
blood pressure and ACE2 using data from adolescents may
improve our understanding of the implication of this gene
in blood pressure regulation. Thus, the aim of this study
was to assess the association between blood pressure and




The Nicotine Dependence in Teens (NDIT) Study is an
ongoing prospective cohort investigation designed to as-
sess the development of nicotine dependence symptoms
after cigarette smoking onset in adolescents [17]. Partici-
pants were recruited in a convenience sample of ten
French and English schools in Montreal. Schools were
located in urban, suburban and rural settings, and par-
ticipants were of varying socio-economic status. A total
of 1,293 students in grade 7 (12–13 years of age) partici-
pated in the baseline assessment in 1999–2000.
Participants completed 45-minute self-reported ques-
tionnaires every 3–4 months during the 10-month
school year, for a total of 20 waves of data collection
during high school. Data from the baseline and the first
five years of follow-up were used in this study. Blood
pressure and anthropometric measures were obtained in
survey cycle 1, 12 and 19 during secondary school (when
participants were 12.7, 15.1, and 17.0 years of age on
average, respectively). The blood or saliva samples for
DNA extraction were provided by 852 of the 1293 par-
ticipants (65.9%) in 2002 and 2007. All participants and
a parent or guardian provided written informed consent
at baseline; a separate consent was provided by parents
for the blood draw in grade 9 (when participants were
14–15 years of age), and informed consent was obtained
from participants (who had attained legal age) for saliva
samples in 2007. The study was approved by Institutional
Review Boards at the CRCHUM, the Direction de santé
publique de Montreal and McGill University.Measurements
After voiding and a 5-minute rest, blood pressure was mea-
sured on the right arm of seated subjects according to a
standardized protocol by a trained and certified technician.
Measurements were made with an automated oscillometric
device (Dinamap XL, model CR9340; Critikon Company
LLC, Tampa, Florida) calibrated against a mercury sphyg-
momanometer before each data collection period. SBP and
DBP were measured 3 times at 1-minute intervals. If the
SBP and DBP measurements differed by more than 10 and
5 mmHg respectively, fourth and fifth measurements were
obtained. The mean of the two closest measurements (after
exclusion of the first measurement) was used for analysis.
Covariates
Duplicate measurements of height and weight were ob-
tained with participants wearing light clothing without
shoes, using a stadiometer (model 214 Road Rod; Seca
Corp., Hanover, MD, USA) for height and a scale (floor
model 761; Seca Corp., Hanover, MD, USA) for weight.
A third measurement was obtained if the difference be-
tween the two measurements was greater than 0.5 cm
for height and 0.2 kg for weight. The average of the two
closest measurements was used in the analysis. To assess
inter-rater reliability of height and weight, measures of
every 1 in 10 participants were repeated. Inter-rater reli-
abilities were 0.99 for height and weight [18,19]. Sex-
and age-specific body mass index (BMI) percentiles were
assessed and youth were categorized as overweight or
obese if the BMI was ≥ 85th percentile according to the
Centers for Disease Control and Prevention guidelines
[20]. The date of birth and sex of participants were self-
reported in the questionnaire.
SNP selection and genotyping
We used the greedy pairwise tagging approach [21] as im-
plemented in the software Haploview [22] in order to tag
polymorphisms present in the HapMap CEU data. We se-
lected SNPs with a minor allele frequency >5%. We used a
linkage disequilibrium (LD) cutoff of r2 > 0.8, ensuring that
each unmeasured SNP is in strong LD with a tag SNP. We
tagged polymorphisms from 10 kb before to 10kb after the
location of ACE2 using genomic positions according to
NCBI build 36. The four selected tag SNPs (rs2074192,
rs233575, rs2158083 and rs1978124) were genotyped at the
McGill University and Genome Quebec Innovation Center
using iPLEX Gold technology (Sequenom, San Diego, Calif,
USA).
Data analysis
Participants with only one or two blood pressure mea-
surements during the five years of high school were ex-
cluded from analyses because of the potential for over
fitting. Because females begin puberty before males, and
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and females in adolescence [23,24], the analyses were
stratified by sex. Differences in demographic and base-
line characteristics between males and females were
tested with chi-squares and t-tests, and differences in
SBP or DBP change over time were tested with general
linear models and paired t-tests as appropriate. Because
the ACE2 gene is located on the X chromosome, males
have only one allele of the ACE2 gene while females
have two. However, which of the alleles is expressed is
unknown in heterozygous females, and therefore we re-
stricted our analyses to males and homozygous females
for each specific SNP, as has been done in the literature
[25]. We tested Hardy-Weinberg Equilibrium in females.
Differences in allele frequencies between males and fe-
males and LD were assessed with χ2 tests.
Due to evidence of heterogeneity between ethnicities,
analyses were also stratified by ethnicity (French Canadian,
European, Other). Analyses assessing the association be-
tween baseline blood pressure and the major and minor
SNP genotypes were conducted with linear regression ana-
lyses. Major and minor SNP genotypes were identified in
accordance with the dbSNP database [26]. A linear growth
curve model with an unstructured error covariance struc-
ture was used to assess the association between SBP or
DBP, and change of SBP or DBP with the four ACE2 SNPs.
SBP and DBP were modeled as continuous variables in sep-
arate models; time was represented by age centered at 12
years, ethnicity was defined as French Canadian, European
descent, or Other (biological parents from Asian, Spanish,
African, etc., countries), and the major allele genotypes
served as the reference category (GG for rs2074192 and
rs1978124, and TT for rs233575 and rs2158083 for females;
G for rs2074192 and rs1978124, and T for rs233575 and
rs2158083 for males). All models adjusted for height and
whether or not the participant was overweight or obese.
Statistical analyses were carried out using SAS 9.2 software
(SAS Institute Inc., Cary, NC, USA).
Results
Participants with fewer than three blood pressure mea-
surements (n = 570), or those who did not provide a
blood or saliva sample (n = 168) were excluded. There-
fore a total of 555 participants of the original 1,293 were
retained for analyses. At baseline, adolescents who were
excluded were significantly younger than those retained
in analyses (12.6 years old compared to 12.9, p < 0.05)
but did not differ in sex, ethnicity, whether or not they
were overweight or obese, SBP or DBP (p > 0.05, data
not shown).
Over half (52%) of the participants in the complete sam-
ple (n = 555) were male (Table 1). Females were not signifi-
cantly different from males in age, ethnicity, BMI, or
baseline SBP or DBP. Mean SBP at baseline was 105mmHg and 104 mmHg in males and females, respectively
and mean baseline DBP was 56 mmHg and 56 mmHg in
males and females respectively. SBP was moderately corre-
lated with DBP in wave 1, 12, and 19 (Pearson r = 0.55,
0.59, and 0.59, respectively). These results were unchanged
after excluding heterozygote females (data not shown). SBP
was statistically significantly lower in females than males at
both follow-ups (p < 0.0001 in wave 12 and wave 19), but
DBP was not statistically significantly different (p > 0.05 in
wave 12 and wave 19). SBP increased 10.1 mmHg on aver-
age over the 5-year follow-up (p < 0.0001) in males, and in-
creased 2.0 mmHg on average in females (p = 0.0003), a
statistically significant difference (p < 0.0001). DBP in-
creased 3.4 mmHg on average over the 5-year follow-up in
males (p < 0.0001), and 2.2 mmHg on average in females
(p < 0.0001), but the difference was not statistically signifi-
cant by sex (p > 0.05). These results were unchanged after
excluding heterozygote females (data not shown).
As mentioned in our methods, we excluded heterozy-
gous females from analyses for each specific SNP result-
ing in analytic samples that ranged from 407–415
participants. Allele frequencies stratified by ethnicity
were compared between males and females and were
not statistically significantly different (Table 2), except
for rs2074192 which had an A allele frequency of 25% in
French Canadian males compared to 44% in French
Canadian females (p = 0.01), and an A allele frequency of
27% in males of other ethnicity compared to 41% in fe-
males of other ethnicity (p = 0.01). SNPs rs233575,
rs2158083, and rs1978124 were in Hardy-Weinberg
Equilibrium (p > 0.05, data not shown). All SNPs were in
linkage disequilibrium with each other (Additional file 1:
Table S1).
SNPs and baseline blood pressure
In multivariable linear regression analyses, SNP rs1978124
was not associated with SBP or DBP at baseline in either
males or females (p > 0.05 for all, Additional file 2:
Table S2). Among males of European descent, carrying the
G allele of SNP rs2074192 was associated with higher DBP
at baseline (56 mmHg vs 53 mmHg, p < 0.05), and the T al-
lele of SNP rs233575 was associated with lower SBP (104
mmHg vs 108 mmHg, p < 0.05) and DBP (54 mmHg vs 56
mmHg, p < 0.05). French Canadian females carrying the T
allele for rs233575 or rs2158083 had baseline DBP that was
4 mmHg higher (59 mmHg vs 55 mmHg) than French
Canadian females carrying the C allele (p < 0.05).
SNPs and blood pressure, or SNPS and blood pressure
change (males)
Sex- and ethnicity-stratified analyses suggested that after
adjusting for height and weight status, SBP and DBP in
males of European descent carrying the A allele of
rs2074192 were 3.3 mmHg lower (p = 0.02) and 2.3







Age, years, mean (SD)3 12.7 (0.42) 12.6 (0.39) 0.06
Ethnicity, %
French Canadian 29 32 0.71
European descent 47 43
Other 24 25
Overweight or obese, % 27 21 0.11
SBP, mmHg, mean (SD)
Baseline (~13 years of age) 105.3 (10.2) 104.5 (9.7) 0.36
Wave 12 (~15 years of age) 109.1 (11.2) 104.1 (10.0) <0.0001
Wave 19 (~17 years of age) 115.4 (11.5) 106.6 (10.4) <0.0001
DBP, mmHg, mean (SD)
Baseline (~13 years of age) 55.6 (6.0) 56.5 (6.2) 0.08
Wave 12 (~15 years of age) 56.7 (5.7) 57.4 (6.5) 0.19
Wave 19 (~17 years of age) 58.9 (6.3) 58.6 (6.3) 0.58
1Baseline measurements unless otherwise noted; 2difference between males
and females; 3SD: Standard deviation.
Malard et al. BMC Medical Genetics 2013, 14:117 Page 4 of 7
http://www.biomedcentral.com/1471-2350/14/117mmHg lower (p = 0.003), respectively than in males of
European descent carrying the G allele (Table 3). In con-
trast, the SBP and DBP of males of European descent
carrying the rs233575 C allele were 3.6 mmHg (p = 0.01)
and 2.4 mmHg higher (p = 0.003), respectively, than in
males of European descent carrying the T allele. In
addition, males carrying the C allele of rs2158083 had
SBP that was 3.4 mmHg higher (p = 0.02) than males
carrying the T allele. French-Canadian males with the C
allele of rs233575 and rs2158083 had 2.9 mmHg
(p = 0.001) and 2.7 mmHg (p = 0.01) lower DBP than
males with the T allele of these respective SNPs. There
were no statistically significant associations between any
of the four SNPs and change in SBP or DBP during
follow-up among boys (data not shown).
SNPs and blood pressure, or SNPS and blood pressure
change (females)
In general none of the SNPs were associated with either
SBP or DBP in females after adjustment for covariates (dataTable 2 Frequency of the minor alleles stratified by sex and e
French Canadian
SNP (Minor/Major)1,2 Male Female p3 M
rs2074192 (A/G) 24.7% 43.9% <0.01 47
rs233575 (C/T) 41.9% 36.8% 0.35 37
rs2158083 (C/T) 37.7% 37.5% 0.98 40
rs1978124 (A/G) 45.4% 49.4% 0.46 55
1Depending on the SNP, n ranged from 142 to 150 female, and 257 to 264 male pa
dbSNP database; 3Comparison of frequencies between males and females.not shown). However, there were statistically significant as-
sociations between several SNPs and change in SBP among
females (Table 4). Females of European descent carrying
the A allele of rs2074192 had a change in SBP during
follow-up that was 1.5 mmHg lower than females of
European descent carrying the G allele (p = 0.002). Females
of European descent carrying the C allele of rs233575 and
rs2158083 had a change in their SBP that was 1.9 mmHg
(p = 0.002) and 1.20 mmHg (p = 0.04) higher, respectively,
compared to females of European descent carrying the T
allele.
Discussion
As a part of the renin-angiotensin aldosterone system,
an important regulator of blood pressure homeostasis,
ACE2 is believed to have a role in blood pressure regula-
tion [9]. Indeed, ACE2 catalyzes the conversions of
Angiotensin I and II into Angiotensin 1–7 which is
known to have a vasodilator function [7,8]. Moreover,
strong biological evidence from animal models suggests
that the ACE2 gene is a regulator of blood pressure
[7-12]. However, the human genetic literature is mixed
with some studies reporting a relationship between
ACE2 SNPs and blood pressure [15,16] while others do
not [11,13,14].
To the best of our knowledge, our study is the first to
investigate the association between tag SNPs in the
ACE2 gene with blood pressure and blood pressure
change in adolescents using multiple measures of blood
pressure over five years of follow-up. Interestingly, we
observed two associations (rs2074192 and rs233575) in
males and females that were entirely driven by partici-
pants of European ancestry. Our results indicate that the
ACE2 gene and more specifically, the major allele of
rs2074192 and the minor allele of rs233575 significantly
increase SBP and DBP among males of European ances-
try, and significantly increase SBP change among females
of European ancestry.
All previous studies on the ACE2 gene were carried
out in adults using cross-sectional or case–control de-
signs with single-point estimates, or follow-up time less
than a month. In contrast, our study utilized nearly five
years of follow-up among adolescents. The use ofthnicity (NDIT Study, 1999–2005)
European Other
ale Female p3 Male Female p3
.1% 46.8% 0.93 26.6% 40.7% 0.01
.5% 39.9% 0.58 33.3% 23.2% 0.07
.3% 40.4% 0.99 33.3% 23.9% 0.09
.4% 52.0% 0.46 31.2% 31.0% 0.96
rticipants; 2Categorizations of major and minor genotypes in accordance with
Table 3 Association between minor ACE2 alleles and blood pressure differences among males (NDIT Study, 1999–2005)
SBP, mmHg DBP, mmHg
Beta (Confidence interval)1 Beta (Confidence interval)1
SNP2 French Canadian European Other French Canadian European Other
rs2074192 −2.65 (−7.3, 2.0) −3.32 (−6.1, -0.6)3 1.57 (−3.5, 6.6) 0.41 (−2.0, 2.8) −2.32 (−3.8, -0.8)4 −1.18 (−4.1, 1.7)
rs233575 −1.05 (−5.3, 3.2) 3.59 (0.8, 6.4)5 −1.05 (−5.9, 3.8) −2.88 (−5.0. -0.8)6 2.42 (0.8, 4.0)7 −1.24 (−4.0, 1.6)
rs2158083 −1.85 (−6.0, 2.3) 3.40 (0.6-6.2)8 −0.32 (−5.2, 4.6) −2.66 (−4.8. -0.6)9 1.33 (−0.3-2.9) −0.20 (−3.0, 2.6)
rs1978124 −2.01 (−6.0, 2.0) 2.00 (−0.8, 4.8) 1.79 (−3.0, 6.6) −1.29 (−3.3, 0.8) 0.73 (−0.9, 2.4) 0.90 (−1.9, 3.7)
1Adjusted for height, and whether or not the participant was overweight or obese; 2Reference groups were the major genotypes in accordance with dbSNP
database: G for rs2074192 and rs1978124; T for rs233575 and rs2158083; 3p-value=0.02; 4p-value=0.003; 5p-value=0.01; 6p-value=0.001; 7p-value=0.003;
8p-value=0.02; 9p-value=0.01.
Malard et al. BMC Medical Genetics 2013, 14:117 Page 5 of 7
http://www.biomedcentral.com/1471-2350/14/117multiple blood pressure measurements in longitudinal
data are less affected by random sources of variation
than measurements taken at one time [27] and thus can
provide stronger evidence for an association. Consistent
with an intervention study among Han Chinese at high-
risk for hypertension [28], rs2074192 was statistically
significantly associated with DBP and SBP among the
males in our study. Consistent with previous studies in
German and Han Chinese populations, our results did
not detect any associations between blood pressure and
rs1978124 [11,14].
Our study is not without limitations. Candidate gene
studies and Genome Wide Association Studies have both
been criticized for their low replication of results, and can-
didate gene studies are additionally criticized for the sub-
jectivity of their gene selection [29]. However, we selected
the ACE2 gene based on animal models as well as the role
of the gene in blood pressure homeostasis, and our results
are consistent with previous studies conducted among
adults. While candidate gene studies cannot provide an ex-
pansive analysis of all possible causative genes, they can
provide insight into our understanding of biological path-
ways [30]. However, our study was limited to tag-SNPs of
the ACE2 gene and future candidate gene studies would
benefit from replication in larger studies. Due to restricting
our analyses to homozygous females and stratifying by sex
and ethnicity, our sample size varied between analyses and
may be underpowered. Nevertheless, although we did not
adjust for multiple testing, we found significant associations
between tag SNPs and systolic blood pressure changeTable 4 Association between minor ACE2 alleles and blood p
SBP, mmHg change
Beta (Confidence interval)1
SNP2 French Canadian European Other
rs2074192 −0.59 (−1.8, 0.6) −1.54 (−0.6, -2.5)3 −1.48 (−3.2,
rs233575 0.30 (−1.3, 1.9) 1.95 (0.8, 3.1)4 1.41 (−0.6,
rs2158083 −0.05 (−1.4, 1.3) 1.20 (0.1, 2.3)5 2.83 (−0.2,
rs1978124 0.34 (−1.0, 1.7) 0.78 (−0.3, 1.9) 0.04 (−1.4,
1Adjusted for height, and whether or not the participant was overweight or obese;
database: G for rs2074192 and rs1978124; T for rs233575 and rs2158083; 3p-value=0among females that were consistent with the systolic blood
pressure differences among males.
We acknowledge that restricting the analysis to homo-
zygous females discards some information and can lead
to a loss of power. Clayton (2008, 2009) has suggested
tests of associations for SNPs located on the X chromo-
some that take into account X inactivation by giving a
weight of ½ to the heterozygous genotype in females, es-
sentially using an additive coding for the genotype (i.e.,
genotypes are coded as 0, 1, or 2 for the number of
minor alleles) [31,32]. We analyzed our data using this
model in females and obtained very similar results as
those obtained by comparing the two homozygous geno-
types (Additional file 3: Table S3 and Additional file 4:
Table S4). We also used other models of X inactivation,
corresponding to dominant (Additional file 5: Table S5
and Additional file 6: Table S6) and recessive coding of
the genotypes (Additional file 7: Table S7 and Additional
file 8: Table S8) [33], and obtained similar results. Given
the uncertainty in the model of X inactivation, we feel
that it is more conservative to present our analyses ex-
cluding heterozygous females.
While 92% of our participants were Canadian-born, 28%
of their mothers and 37% of their fathers were foreign-
born, and ethnicity has been shown to modify the associ-
ation between SNPs and blood pressure [34]. Our tag SNPs
were selected based on the HapMap data of northern and
western European ancestry, which may not have provided
sufficient coverage in other ethnicities. However, the
“Other” ethnicity group was heterogeneous, and there wereressure change among females (NDIT Study, 1999–2005)
DBP, mmHg change
Beta (Confidence interval)1
French Canadian European Other
0.2) −0.44 (−1.5, 0.6) −0.20 (−1.0, 0.6) −0.32 (−1.7, 1.0)
3.4) 0.87 (−0.3, 2.0) 0.67 (−0.1, 1.4) −0.35 (−2.0, 1.3)
5.9) 0.39 (−0.7, 1.5) 0.53 (−0.2, 1.2) 0.06 (−2.3, 2.4)
1.5) −0.25 (−1.3, 0.8) 0.62 (−0.01, 1.2) −0.45 (−1.6. 0.7)
2Reference groups were the major genotypes in accordance with dbSNP
.002; 4p-value=0.002; 5p-value=0.04.
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ing tag SNPs. While insufficient coverage could contribute
to the absence of association detected in the “Other” ethni-
city group, significant results in this group would be ex-
tremely hard to interpret given the possibility of population
stratification bias. Although most SNPs were in Hardy-
Weinberg Equilibrium, there was evidence of a significant
difference in the allele frequencies of rs2074192 between
males and females of “French-Canadian” and “Other” des-
cent. Lastly, puberty in females ends at approximately 15
years of age, and it is possible that blood pressure trajector-
ies change at this time. However we were not able to assess
this given that we only had three blood pressure measure-
ments over time. Additional studies allowing for two differ-
ent slopes in females (before and after age 15 years) may
provide additional insight.Conclusion
Despite these limitations, our results suggest that several
ACE2 gene SNPs are associated with either blood pres-
sure levels or blood pressure change among males and
females of European ancestry. Whether these SNPs
could be new therapeutic targets, or potential primordial
targets in persons of European descent should be further
explored.Additional files
Additional file 1: Table S1. Linkage disequilibrium between SNPs in
homozygous females (NDIT Study, 1999–2005).
Additional file 2: Table S2. Mean blood pressure (mmHg) at baseline
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